NCT01542281

Brief Summary

  1. 1.To determine whether a combined nutritional support program and exercise-based prehabilitation is superior to nutritional support alone in increasing functional recovery and reducing post-operative morbidity after surgery for HPB malignancy.
  2. 2.To understand which measures of immediate surgical recovery are sensitive to prehabilitation interventions and predict change in later outcome measures.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 16, 2012

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 2, 2012

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
Last Updated

March 2, 2012

Status Verified

February 1, 2012

Enrollment Period

2 years

First QC Date

February 16, 2012

Last Update Submit

February 24, 2012

Conditions

Keywords

liver resectionhepatectomypre-habilitation

Outcome Measures

Primary Outcomes (1)

  • Change in six minute walk test

    The primary outcome is patient-relevant, functional walking capacity as measured by the six-minute walk test (6MWT). The 6MWT evaluates the ability of an individual to maintain a moderate level of physical activity over a time period reflective of the activities of daily living

    8 weeks pre-op and 1 week pre-op

Secondary Outcomes (6)

  • post-operative complications

    30 days

  • Health-related quality of life (HRQL)

    8 and 1 week pre-operatively, 4 and 8 weeks post-operatively

  • Physical activity level

    8 and 1 weeks pre-operatively, 4 and 8 weeks post-operatively

  • Depression and anxiety

    8 and 1 weeks pre-operatively, 4 and 8 weeks post-operatively

  • Fatigue

    8 and 1 weeks pre-operatively, 4 and 8 weeks post-operatively

  • +1 more secondary outcomes

Study Arms (2)

Nutritional supplementation and prehab

EXPERIMENTAL

The first group (pre-hab) will receive both nutritional supplementation and a prehabilitation program.

Dietary Supplement: Whey protein and dietary supplements

Prehab exercise

ACTIVE COMPARATOR
Other: prehab exercise

Interventions

Whey protein and dietary supplements in addition to pre-hab exercise

Nutritional supplementation and prehab

minimum 4 weeks and maximum 8 weeks; 3 times a week

Also known as: weight training , walking, cycling etc.
Prehab exercise

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects eligible to enter the prehabilitation program will include those aged 18 and above and referred electively for resection of malignancies.

You may not qualify if:

  • Excluded will be persons with American Society of Anesthesiologists (ASA) health status class 4-5 or co-morbid medical, physical and mental conditions (e.g. dementia, disabling orthopedic and neuromuscular disease, psychosis), cardiac abnormalities, severe end-organ disease such as cardiac failure, COPD, and hepatic failure (ALT and AST \>50% over the normal range), and sepsis), morbid obesity (BMI \>40), anemia (hematocrit \< 30 %) and other conditions interfering with the ability to perform exercise at home or to complete the testing procedures.
  • Patients will be excluded if they have poor English or French comprehension.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Victoria Hospital

Montreal, Quebec, H3A1A1, Canada

RECRUITING

MeSH Terms

Conditions

Colorectal NeoplasmsBiliary Tract NeoplasmsLiver Neoplasms

Interventions

Whey ProteinsDietary SupplementsWalking

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesBiliary Tract DiseasesLiver Diseases

Intervention Hierarchy (Ancestors)

Milk ProteinsAnimal Proteins, DietaryDietary ProteinsProteinsAmino Acids, Peptides, and ProteinsWheyMilkDairy ProductsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesLocomotionMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExerciseMotor Activity

Study Officials

  • Prosanto Chaudhury, MD

    McGill University Health Centre/Research Institute of the McGill University Health Centre

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ayat Salman, MSccandidate

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
HPB and Transplant Surgeon

Study Record Dates

First Submitted

February 16, 2012

First Posted

March 2, 2012

Study Start

January 1, 2012

Primary Completion

January 1, 2014

Study Completion

January 1, 2015

Last Updated

March 2, 2012

Record last verified: 2012-02

Locations